Jose M. Sustaeta-Echave
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Health-related quality of life in European older adults with respiratory syncytial virus over three respiratory syncytial virus seasons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 03, 2025
Burden of Respiratory Syncytial Virus Among Older Adults With an Acute Respiratory Infection: A Prospective Study in Six European Countries.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 03, 2025
Burden of respiratory syncytial virus among older adults with an acute respiratory infection: a prospective study in six European countries.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 03, 2025
Health-related Quality of Life in European Older Adults with Respiratory Syncytial Virus Over Three Respiratory Syncytial Virus Seasons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 03, 2025
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
Journal: Archivos de bronconeumologia
Published: March 04, 2024
Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 21, 2023
The ANTES program in COPD: First year.
Journal: Archivos de bronconeumologia
Published: October 29, 2021
Characterization of COPD Admissions During the First COVID-19 Outbreak.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 25, 2021
Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT.
Journal: Therapeutic advances in respiratory disease
Published: October 30, 2020
Microspirometers in the Follow-Up of COPD: Advantages and Disadvantages.
Journal: Archivos de bronconeumologia
Published: April 15, 2020
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
Journal: International journal of chronic obstructive pulmonary disease
Published: February 20, 2016
Last Updated: 09/26/2026